Eko Foundation Analysis Software with Transformers (EFAST) vs AI-ECG Platform
AI Verdict
Choose Eko Foundation Analysis Software with Transformers (EFAST) if…
Choose EFAST if you require real-time, AI-powered assistance during routine auscultation to quickly identify structural murmurs and atrial fibrillation. This tool is ideal for clinicians seeking immediate cardiac insights at the point of care, seamlessly integrating with Eko digital stethoscopes for enhanced audio and guided exams.
View Eko Foundation Analysis Software with Transformers (EFAST) →Choose AI-ECG Platform if…
Choose the AI-ECG Platform if your primary need is highly accurate, automated analysis and diagnosis of 12-lead resting ECGs. This system is best suited for specialties like emergency medicine or cardiology, where comprehensive interpretation of various cardiovascular conditions, including arrhythmias and myocardial events, is critical, regardless of the ECG machine used.
View AI-ECG Platform →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | AI-ECG Platform |
|---|---|---|
| Pricing | Subscription-based, contact for details | Contact for pricing |
| Deployment | Cloud-based Software as a Medical Device (SaMD) | Workstation (with GPU), web-based portal, Windows-based diagnostic client |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Foundation Analysis Software with Transformers (EFAST)Tool A emphasizes a seamless, real-time experience integrated with its own hardware (Eko digital stethoscopes), offering AI analysis during auscultation. This integrated workflow is likely more intuitive and less disruptive to existing clinical examination processes compared to Tool B's multiple deployment options and post-acquisition analysis.
Clinical Value
AI-ECG PlatformWhile Tool A provides valuable real-time detection of structural murmurs and AFib, Tool B offers broader clinical value by diagnosing a wider range of major cardiovascular diseases from a standard 12-lead ECG, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. Both are FDA-cleared and demonstrate high accuracy in their respective areas.
Pricing & Value
Eko Foundation Analysis Software with Transformers (EFAST)Tool A provides more transparency regarding its pricing model, explicitly stating it is subscription-based with a yearly membership and an estimated daily cost for associated hardware. Tool B only states 'contact for pricing,' offering no public details on its cost structure.
Enterprise Readiness
Eko Foundation Analysis Software with Transformers (EFAST)Tool A demonstrates stronger enterprise readiness with explicit statements of HIPAA compliance and Business Associate Agreement (BAA) availability, alongside its cloud-based Software as a Medical Device (SaMD) deployment and EMR integration. While Tool B offers flexible deployment and broad ECG data format support, its BAA and HIPAA compliance are not explicitly stated in the provided information.
Innovation
Eko Foundation Analysis Software with Transformers (EFAST)Tool A demonstrates greater innovation by leveraging advanced AI (Transformers) for real-time analysis during auscultation, directly integrating with a digital stethoscope to augment the physical exam at the point of care. This represents a more novel application compared to the more established field of AI-powered ECG interpretation, even if highly accurate.
Support & Docs
Eko Foundation Analysis Software with Transformers (EFAST)Eko Health (Tool A) provides a robust and publicly accessible support infrastructure, including a dedicated Help Center with articles, FAQs, user manuals, and multiple contact options like phone, email, and live chat. While Shenzhen Carewell Electronics (Tool B) offers technical support, the public information suggests a less detailed or comprehensive self-service knowledge base compared to Eko.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | AI-ECG Platform |
|---|---|---|
| Name | Eko Foundation Analysis Software with Transformers (EFAST) | AI-ECG Platform |
| Company | Eko Health | Shenzhen Carewell Electronics Co., Ltd. |
| Primary Modality/Focus | Auscultation (structural murmurs, atrial fibrillation) | 12-lead resting ECG analysis |
| Key AI Detections/Diagnoses | Structural murmur detection, Atrial Fibrillation (AFib) detection | Arrhythmias, ventricular hypertrophy, myocardial ischemia, myocardial infarction, major cardiovascular diseases |
| Stated Accuracy | Structural murmur detection (93% sensitivity, 91% specificity); AFib detection (95% sensitivity, 94% specificity) | Over 95% accuracy in diagnosing major cardiovascular diseases |
Videos
Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and AI-ECG Platform.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Foundation Analysis Software with Transformers (EFAST) or AI-ECG Platform
Backers
Who funded each tool's parent company.